参考文献/References:
[1]Elzamzamy OM,Penner R,Hazlehurst LA.The Role of TRPC1 in Modulating Cancer Progression[J].Cells,2020,9(2):388.[2]Tai YK,Chan KKW,Fong CHH,et al.Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach[J].Front Oncol,2022,11:783803.[3]Azimi I,Milevskiy MJG,Kaemmerer E,et al.TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells[J].J Cell Sci,2017,130(14):2292-2305.[4]张荣,陈婧,黄江涛,等.TRPC3在胰腺癌细胞系中的表达及功能[J].现代肿瘤医学,2020,28(15):2560-2565.[5]Selli C,Pearce DA,Sims AH,et al.Differential expression of store-operated calcium- and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing[J].Mol Cell Biochem,2016,420(1-2):129-140.[6]Guéguinou M,Harnois T,Crottes D,et al.SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline[J].Oncotarget,2016,7(24):36168-36184.[7]Bomben VC,Sontheimer H.Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas[J].Glia,2010,58(10):1145-1156.[8]Jiang HN,Zeng B,Zhang Y,et al.Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer[J].PLoS One,2013,8(6):e67637.[9]Asghar MY,Magnusson M,Kemppainen K,et al.Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION[J].J Biol Chem,2015,290(26):16116-16131.[10]Zhang LY,Zhang YQ,Zeng YZ,et al.TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway[J].Breast Cancer Res Treat,2020,182(1):21-33.[11]Zeng YZ,Zhang YQ,Chen JY,et al.TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma[J].Front Oncol,2021,11:627713.[12]Yang Z,Wang YG,Su K.VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue[J].Asian Pac J Cancer Prev,2015,16(1):271-274.[13]Detre S,Saclani Jotti G,Dowsett M.A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas[J].J Clin Pathol,1995,48(9):876-878.[14]McClelland RA,Finlay P,Walker KJ,et al.Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer[J].Cancer Res,1990,50(12):3545-3550.[15]Treppiedi E,Giacopuzzi S,de Pascale S.Adenocarcinoma of the esophagogastric junction; going up or down?[J].Gastric Cancer,2020,23(5):948-949.[16]Pang T,Nie M,Yin K.The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma[J].World J Surg Oncol,2023,21(1):316.[17]Pottier C,Wheatherspoon A,Roncarati P,et al.The importance of the tumor microenvironment in the therapeutic management of cancer.Expert Rev Anticancer Ther.2015;15(8):943-954.[18]杨敏,蒋敬庭,卢斌峰.肿瘤浸润CD8+T淋巴细胞的功能缺失分子机制[J].临床检验杂志,2016,34(1):42-45.[19]Li SM,Gong YX,Zhang ZZ,et al.Effect of Radical Surgery for Advanced Adenocarcinoma of Esophagogastric Junction on Perioperative Cellular Cell Immunity[J].J Invest Surg,2021,34(2):134-141.[20]Wang J,Sanmamed MF,Datar I,et al.Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3[J].Cell,2019,176(1-2):334-347.e12.[21]Chen Z,Zhao M,Liang J,et al.Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma[J].E Bio Medicine,2021,69:103459.